(Press-News.org) In an advance that could dramatically shrink particle accelerators for science and medicine, researchers used a laser to accelerate electrons at a rate 10 times higher than conventional technology in a nanostructured glass chip smaller than a grain of rice.
The achievement was reported today in Nature by a team including scientists from the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory and Stanford University.
"We still have a number of challenges before this technology becomes practical for real-world use, but eventually it would substantially reduce the size and cost of future high-energy particle colliders for exploring the world of fundamental particles and forces," said Joel England, the SLAC physicist who led the experiments. "It could also help enable compact accelerators and X-ray devices for security scanning, medical therapy and imaging, and research in biology and materials science."
Because it employs commercial lasers and low-cost, mass-production techniques, the researchers believe it will set the stage for new generations of "tabletop" accelerators.
At its full potential, the new "accelerator on a chip" could match the accelerating power of SLAC's 2-mile-long linear accelerator in just 100 feet, and deliver a million more electron pulses per second.
This initial demonstration achieved an acceleration gradient, or amount of energy gained per length, of 300 million electronvolts per meter. That's roughly 10 times the acceleration provided by the current SLAC linear accelerator.
"Our ultimate goal for this structure is 1 billion electronvolts per meter, and we're already one-third of the way in our first experiment," said Stanford Professor Robert Byer, the principal investigator for this research.
Today's accelerators use microwaves to boost the energy of electrons. Researchers have been looking for more economical alternatives, and this new technique, which uses ultrafast lasers to drive the accelerator, is a leading candidate.
Particles are generally accelerated in two stages. First they are boosted to nearly the speed of light. Then any additional acceleration increases their energy, but not their speed; this is the challenging part.
In the accelerator-on-a-chip experiments, electrons are first accelerated to near light-speed in a conventional accelerator. Then they are focused into a tiny, half-micron-high channel within a fused silica glass chip just half a millimeter long. The channel had been patterned with precisely spaced nanoscale ridges. Infrared laser light shining on the pattern generates electrical fields that interact with the electrons in the channel to boost their energy. (See the accompanying animation for more detail.)
VIDEO:
This animation shows how our accelerator on a chip uses laser light to boost electron energy. In the accelerator-on-a-chip experiments, electrons are first accelerated to near light-speed in a conventional...
Click here for more information.
Turning the accelerator on a chip into a full-fledged tabletop accelerator will require a more compact way to get the electrons up to speed before they enter the device.
A collaborating research group in Germany, led by Peter Hommelhoff at the Max Planck Institute of Quantum Optics, has been looking for such a solution. It simultaneously reports in Physical Review Letters its success in using a laser to accelerate lower-energy electrons.
Applications for these new particle accelerators would go well beyond particle physics research. Byer said laser accelerators could drive compact X-ray free-electron lasers, comparable to SLAC's Linac Coherent Light Source, that are all-purpose tools for a wide range of research.
Another possible application is small, portable X-ray sources to improve medical care for people injured in combat, as well as provide more affordable medical imaging for hospitals and laboratories. That's one of the goals of the Defense Advanced Research Projects Agency's (DARPA) Advanced X-Ray Integrated Sources (AXiS) program, which partially funded this research. Primary funding for this research is from the DOE's Office of Science.
INFORMATION:
The study's lead authors were Stanford graduate students Edgar Peralta and Ken Soong. Peralta created the patterned fused silica chips in the Stanford Nanofabrication Facility. Soong implemented the high-precision laser optics for the experiment at SLAC's Next Linear Collider Test Accelerator. Additional contributors included researchers from the University of California-Los Angeles and Tech-X Corp. in Boulder, Colo.
SLAC is a multi-program laboratory exploring frontier questions in photon science, astrophysics, particle physics and accelerator research. Located in Menlo Park, California, SLAC is operated by Stanford University for the U.S. Department of Energy Office of Science. To learn more, please visit http://www.slac.stanford.edu.
DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov
Citation: E. A. Peralta et al., Nature, 27 Sept 2013 (10.1038/nature12664)
Researchers demonstrate 'accelerator on a chip'
Technology could spawn new generations of smaller, less expensive devices for science, medicine
2013-09-28
ELSE PRESS RELEASES FROM THIS DATE:
Survival after cancer diagnosis in Europe associated with amount governments spend on health care
2013-09-28
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2].
Researchers will tell the meeting that higher wealth and higher health expenditure are strongly associated both with increased cancer incidence and decreased cancer mortality. In the case of breast cancer, increased health expenditure appears to be ...
Colorectal cancer screening works
2013-09-28
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Sunday).
Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France, will report on results extracted from data on CRC ...
Diabetes increases the risk of developing and dying from breast and colon cancer
2013-09-28
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
Dr Kirstin De Bruijn will tell the 2013 European Cancer Congress (ECC2013) [1], today (Sunday), that previous studies have examined the association between diabetes and dying from cancer but death from specific types of cancer has not been well-studied. "Our meta-analysis ...
Young patients with metastatic colorectal cancer are at high risk of disease progression and death
2013-09-28
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday).
An analysis of 20,034 patients in 24 phase III clinical trials [2] for colorectal cancer, of which 695 patients (3%) were younger than 40, showed that the youngest and oldest patients ...
Everolimus slows disease progression in advanced papillary kidney cancer patients
2013-09-28
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress (ECC2013) [1].
Dr Bernard Escudier, Head of the French Group of Immunotherapy and chairman of the Genitourinary tumour board at the Institut Gustave Roussy in Villejuif, France will say: "Our results showed that for 59% of patients who received everolimus ...
Combining Chinese and Western medicine could lead to new cancer treatments
2013-09-28
Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.
Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine.
The team also set-out to examine how by combining it with more traditional methods like Chemotherapy could improve patient outcomes and potentially lead to the development of new cancer treatments and therapies.
"Traditional ...
Yoga in menopause may help insomnia -- but not hot flashes
2013-09-28
Seattle, WA—Taking a 12-week yoga class and practicing at home was linked to less insomnia—but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial.
"Many women suffer from insomnia during menopause, and it's good to know that yoga may help them," said lead author Katherine Newton, PhD, a senior investigator at Group Health Research Institute. She e-published ...
First step to reduce plant need for nitrogen fertilizer uncovered
2013-09-28
COLUMBIA, Mo. — Nitrogen fertilizer costs U.S. farmers approximately $8 billion each year, and excess fertilizer can find its way into rivers and streams, damaging the delicate water systems. Now, a discovery by a team of University of Missouri researchers could be the first step toward helping crops use less nitrogen, benefitting both farmers' bottom lines and the environment. The journal Science published the research this month.
Gary Stacey, an investigator in the MU Bond Life Sciences Center and professor of plant sciences in the College of Agriculture, Food and Natural ...
SUNRISE offers new insight on sun's atmosphere
2013-09-28
Three months after the flight of the solar observatory Sunrise – carried aloft by a NASA scientific balloon in early June 2013 -- scientists from the Max Planck Institute for Solar System Research in Germany have presented unique insights into a layer on the sun called the chromosphere. Sunrise provided the highest-resolution images to date in ultraviolet light of this thin corrugated layer, which lies between the sun's visible surface and the sun's outer atmosphere, the corona.
With its one-meter mirror, Sunrise is the largest solar telescope to fly above the atmosphere. ...
New research reveals that oxytocin could make us more accepting of others
2013-09-28
(New York, New York) September 27, 2013 - Oxytocin - often referred to as the 'love hormone' because of its ability to promote mother-infant attachment and romantic bonding in adults - could also make us more accepting of other people, as found in new research, "Oxytocin Sharpens Self-other Perceptual Boundary," by Neuropsychoanalysis Foundation research grantee Valentina Colonnello Ph.D. published online today in Psychoneuroendocrinology.
Together with Dr. Markus Heinrichs from the Department of Psychology at the University of Freiburg in Germany, Dr. Colonnello found ...
LAST 30 PRESS RELEASES:
Father’s mental health can impact children for years
Scientists can tell healthy and cancerous cells apart by how they move
Male athletes need higher BMI to define overweight or obesity
How thoughts influence what the eyes see
Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect
Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation
Could opioid laws help curb domestic violence? New USF research says yes
NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow
Scientists identify agent of transformation in protein blobs that morph from liquid to solid
Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss
Research identifies key enzyme target to fight deadly brain cancers
New study unveils volcanic history and clues to ancient life on Mars
Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome
Scientists probe the mystery of Titan’s missing deltas
Q&A: What makes an ‘accidental dictator’ in the workplace?
Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture
Study highlights gaps in firearm suicide prevention among women
People with medical debt five times more likely to not receive mental health care treatment
Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B
Rise in claim denial rates for cancer-related advanced genetic testing
Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use
Medical debt and forgone mental health care due to cost among adults
Colder temperatures increase gastroenteritis risk in Rohingya refugee camps
Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine
Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury
AERA announces winners of the 2025 Palmer O. Johnson Memorial Award
Mapping minds: The neural fingerprint of team flow dynamics
Patients support AI as radiologist backup in screening mammography
AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy
Existing drug has potential for immune paralysis
[Press-News.org] Researchers demonstrate 'accelerator on a chip'Technology could spawn new generations of smaller, less expensive devices for science, medicine